|
Category:
|
Enzymes Phosphodiesterases
|
|
Cat.No.
|
Product Name
|
|
1692 |
Cilostazol
|
|
|
|
Price and Availability
Click here for full price details of
Cilostazol
|
|
Chemical Name:
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro
-2(1H)-quinolinone |
|
|
Biological Activity:
Potent
phosphodiesterase III A (PDE3A) inhibitor (IC50 = 0.2 μM) and inhibitor of adenosine uptake.
Has antimitogenic, antithrombotic, vasodilatory and cardiotonic properties in
vivo. Also affects lipid levels in vivo.
|
Technical Data:
|
|
|
Resources:
|
|
Certificate of Analysis / MSDS:
|
References:
Shintani et al (1985) General
pharmacological properties of cilostazol, a new antithrombotic drug. Part I:
effects on the central nervous system. Arzneim.-Forsch. 35 1157. Shintani
et al (1985) General pharmacological properties of cilostazol, a new
antithrombotic drug. Part II: effects on the peripheral organs.
Arzneim.-Forsch. 35 1163. Schror (2002) The pharmacology
of cilostazol. Diabetes Obes.Metab. 4 S14.
|
|
View related products by Pharmacological Action
or by Research Area
Keywords: Cilostazol, Phosphodiesterases, PDE3A Inhibitor. Also Adenosine Uptake Inhibitor, Tocris Bioscience
|
|
Literature in this Area Signal Transduction Guide | A complete listing of signal transduction products available from Tocris, including descriptions on selected tools and unit sizes. | | View PDF |
|
